Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port

Abstract Central venous port (CVP) is a widely used totally implantable venous access device. Recognition of risks associated with CVP-related complications is clinically important for safe, reliable, and long-term intravenous access. We therefore investigated factors associated with CVP infection a...

Full description

Bibliographic Details
Main Authors: Yuuki Iida, Kumiko Hongo, Takanobu Onoda, Yusuke Kita, Yukio Ishihara, Naoki Takabayashi, Ryo Kobayashi, Takeyuki Hiramatsu
Format: Article
Language:English
Published: Nature Portfolio 2021-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-84885-4
_version_ 1818421483701010432
author Yuuki Iida
Kumiko Hongo
Takanobu Onoda
Yusuke Kita
Yukio Ishihara
Naoki Takabayashi
Ryo Kobayashi
Takeyuki Hiramatsu
author_facet Yuuki Iida
Kumiko Hongo
Takanobu Onoda
Yusuke Kita
Yukio Ishihara
Naoki Takabayashi
Ryo Kobayashi
Takeyuki Hiramatsu
author_sort Yuuki Iida
collection DOAJ
description Abstract Central venous port (CVP) is a widely used totally implantable venous access device. Recognition of risks associated with CVP-related complications is clinically important for safe, reliable, and long-term intravenous access. We therefore investigated factors associated with CVP infection and evulsion, including the device type. A total of 308 consecutive patients with initial CVP implantation between January 2011 and December 2017 were retrospectively reviewed, and the association of clinical features with CVP-related complications were analyzed. Intraoperative and postoperative complications occurred in 11 (3.6%) and 39 (12.7%) patients, respectively. The overall rate of CVP availability at six months was 91.4%. Malignancy and 2-Methacryloyloxyethyl phosphorylcholine (MPC) polymer-coated catheter use were negatively associated with the incidence of CVP infections. Accordingly, malignancy and MPC polymer-coated catheter use were independent predictors for lower CVP evulsion rate (odds ratio, 0.23 and 0.18, respectively). Furthermore, both factors were significantly associated with longer CVP availability (hazard ratio, 0.24 and 0.27, respectively). This retrospective study identified factors associated with CVP-related complications and long-term CVP availability. Notably, MPC polymer-coated catheter use was significantly associated with a lower rate of CVP infection and longer CVP availability, suggesting the preventive effect of MPC coating on CVP infection.
first_indexed 2024-12-14T13:11:05Z
format Article
id doaj.art-bac3800431be4e28a6d87007f99403b3
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-14T13:11:05Z
publishDate 2021-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-bac3800431be4e28a6d87007f99403b32022-12-21T23:00:12ZengNature PortfolioScientific Reports2045-23222021-03-011111610.1038/s41598-021-84885-4Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous portYuuki Iida0Kumiko Hongo1Takanobu Onoda2Yusuke Kita3Yukio Ishihara4Naoki Takabayashi5Ryo Kobayashi6Takeyuki Hiramatsu7Department of Surgery, Yaizu City HospitalDepartment of Surgery, Yaizu City HospitalDepartment of Surgery, Yaizu City HospitalDepartment of Surgery, Yaizu City HospitalDepartment of Surgery, Yaizu City HospitalDepartment of Surgery, Yaizu City HospitalDepartment of Surgery, Yaizu City HospitalDepartment of Surgery, Yaizu City HospitalAbstract Central venous port (CVP) is a widely used totally implantable venous access device. Recognition of risks associated with CVP-related complications is clinically important for safe, reliable, and long-term intravenous access. We therefore investigated factors associated with CVP infection and evulsion, including the device type. A total of 308 consecutive patients with initial CVP implantation between January 2011 and December 2017 were retrospectively reviewed, and the association of clinical features with CVP-related complications were analyzed. Intraoperative and postoperative complications occurred in 11 (3.6%) and 39 (12.7%) patients, respectively. The overall rate of CVP availability at six months was 91.4%. Malignancy and 2-Methacryloyloxyethyl phosphorylcholine (MPC) polymer-coated catheter use were negatively associated with the incidence of CVP infections. Accordingly, malignancy and MPC polymer-coated catheter use were independent predictors for lower CVP evulsion rate (odds ratio, 0.23 and 0.18, respectively). Furthermore, both factors were significantly associated with longer CVP availability (hazard ratio, 0.24 and 0.27, respectively). This retrospective study identified factors associated with CVP-related complications and long-term CVP availability. Notably, MPC polymer-coated catheter use was significantly associated with a lower rate of CVP infection and longer CVP availability, suggesting the preventive effect of MPC coating on CVP infection.https://doi.org/10.1038/s41598-021-84885-4
spellingShingle Yuuki Iida
Kumiko Hongo
Takanobu Onoda
Yusuke Kita
Yukio Ishihara
Naoki Takabayashi
Ryo Kobayashi
Takeyuki Hiramatsu
Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port
Scientific Reports
title Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port
title_full Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port
title_fullStr Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port
title_full_unstemmed Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port
title_short Use of catheter with 2-methacryloyloxyethyl phosphorylcholine polymer coating is associated with long-term availability of central venous port
title_sort use of catheter with 2 methacryloyloxyethyl phosphorylcholine polymer coating is associated with long term availability of central venous port
url https://doi.org/10.1038/s41598-021-84885-4
work_keys_str_mv AT yuukiiida useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport
AT kumikohongo useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport
AT takanobuonoda useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport
AT yusukekita useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport
AT yukioishihara useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport
AT naokitakabayashi useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport
AT ryokobayashi useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport
AT takeyukihiramatsu useofcatheterwith2methacryloyloxyethylphosphorylcholinepolymercoatingisassociatedwithlongtermavailabilityofcentralvenousport